/
/
/

Riddhi Siddhi Gluco Biols Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018
₹90 Cr₹9 Cr₹40 Cr₹32 Cr₹155 Cr₹28 Cr₹44 Cr₹49 Cr₹14 Cr₹51 Cr₹136 Cr₹18 Cr₹64 Cr₹70 Cr₹22 Cr₹42 Cr₹52 Cr₹45 Cr₹104 Cr₹262 Cr₹110 Cr₹202 Cr₹127 Cr₹116 Cr₹52 Cr₹114 Cr₹270 Cr₹94 Cr₹99 Cr₹148 Cr₹160 Cr₹204 Cr₹170 Cr
₹17 Cr₹11 Cr₹14 Cr₹22 Cr₹21 Cr₹26 Cr₹20 Cr₹21 Cr₹20 Cr₹16 Cr₹20 Cr₹23 Cr₹22 Cr₹16 Cr₹17 Cr₹18 Cr₹15 Cr₹16 Cr₹15 Cr₹17 Cr₹15 Cr₹17 Cr₹15 Cr₹16 Cr₹11 Cr₹13 Cr₹11 Cr₹14 Cr₹12 Cr₹36 Cr₹12 Cr₹10 Cr₹12 Cr
₹107 Cr₹20 Cr₹54 Cr₹54 Cr₹176 Cr₹54 Cr₹65 Cr₹70 Cr₹34 Cr₹67 Cr₹156 Cr₹41 Cr₹86 Cr₹87 Cr₹39 Cr₹60 Cr₹67 Cr₹61 Cr₹119 Cr₹280 Cr₹125 Cr₹220 Cr₹142 Cr₹132 Cr₹63 Cr₹127 Cr₹281 Cr₹108 Cr₹111 Cr₹185 Cr₹172 Cr₹214 Cr₹182 Cr
₹95 Cr₹19 Cr₹48 Cr₹33 Cr₹157 Cr₹34 Cr₹47 Cr₹45 Cr₹17 Cr₹56 Cr₹136 Cr₹17 Cr₹66 Cr₹77 Cr₹25 Cr₹47 Cr₹53 Cr₹56 Cr₹120 Cr₹253 Cr₹118 Cr₹203 Cr₹148 Cr₹134 Cr₹64 Cr₹124 Cr₹250 Cr₹95 Cr₹97 Cr₹126 Cr₹138 Cr₹188 Cr₹188 Cr
₹14 Cr₹3 Cr₹9 Cr₹24 Cr₹21 Cr₹23 Cr₹19 Cr₹28 Cr₹20 Cr₹13 Cr₹23 Cr₹26 Cr₹22 Cr₹13 Cr₹16 Cr₹22 Cr₹17 Cr₹14 Cr₹8 Cr₹36 Cr₹16 Cr₹26 Cr₹3 Cr₹8 Cr₹8 Cr₹13 Cr₹40 Cr₹22 Cr₹23 Cr₹68 Cr₹43 Cr₹35 Cr₹2 Cr
₹6 Cr₹4 Cr₹4 Cr₹5 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹4 Cr₹2 Cr₹4 Cr₹5 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹8 Cr₹6 Cr₹8 Cr₹8 Cr₹7 Cr₹8 Cr₹12 Cr₹5 Cr₹12 Cr₹10 Cr
₹6 Cr-₹4 Cr₹2 Cr₹16 Cr₹15 Cr₹18 Cr₹15 Cr₹23 Cr₹16 Cr₹9 Cr₹18 Cr₹21 Cr₹17 Cr₹8 Cr₹12 Cr₹9 Cr₹12 Cr₹96 L-₹6 Cr₹21 Cr₹1 Cr₹10 Cr-₹12 Cr-₹9 Cr-₹7 Cr-₹4 Cr₹23 Cr₹6 Cr₹6 Cr₹46 Cr₹29 Cr₹14 Cr-₹17 Cr
₹3 Cr-₹33 Cr-₹1 Cr₹14 Cr₹8 Cr₹5 Cr-₹54 Cr₹13 Cr₹24 Cr₹21 Cr₹6 Cr₹10 Cr₹6 Cr-₹92 Cr₹3 Cr₹2 L₹4 Cr-₹4 Cr-₹11 Cr₹17 Cr₹77 L-₹3 Cr-₹31 Cr-₹17 Cr-₹10 Cr₹7 Cr₹15 Cr₹1 Cr₹89 L₹60 Cr₹13 Cr₹11 Cr-₹17 Cr

Share Price Live Stats

Open (₹)769.00
Volume (₹)2.00
High (₹)769.00
Upper Circuit787.50
Low (₹)766.75
Lower Circuit712.50
Prev Close750.00
52W High (₹)861.95
Price766.75
52W Low (₹)405.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)534.73 Cr
Div. Yield (%)0.40
PE Ratio0.00
Debt to Equity0.06
Price to Book0.24
Book Value2,172.72
EPS (TTM)-13.31
Face Value10.00
ROE (%)4.09

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
PREMIERENE-ANSE
AEGISLOG-ANSE
CPPLUS-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
BLACKROSE-TNSE
RIDDHI-XTNSE
LTP
1W Low
1W High
Market cap (₹)
2942-224 (-7.08%)
2831.65
3168
3,90,684Cr
1001.1-12.9 (-1.27%)
995.50
1028.55
45,486Cr
1276.95-12.65 (-0.98%)
1180.45
1327.30
45,144Cr
3734.4+157.45 (4.40%)
3458.85
3796.35
44,346Cr
369.1+3.25 (0.89%)
343.80
378.95
29,113Cr
480+9.25 (1.96%)
465.25
494
15,566Cr
73.15+0.01 (0.01%)
69.53
74.50
10,984Cr
344-7 (-1.99%)
340.85
357.45
7,747Cr
507.65-4.3 (-0.84%)
497.75
529.70
6,238Cr
112.75-2.25 (-1.96%)
110.60
116.95
572Cr
766.75+7.75 (1.02%)
730.10
775
535Cr

Key Highlights of Riddhi Siddhi Gluco Biols Ltd’s P&L

In 2025-03-31, Riddhi Siddhi Gluco Biols Ltd reported total revenue of ₹223.28Cr, compared with ₹348.9Cr in 2024-03-31, reflecting Riddhi Siddhi Gluco Biols Ltd turnover.

Depreciation was ₹8.52Cr and finance costs were ₹9.76Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹71.48Cr in 2025-03-31 as compared to ₹64.71Cr in 2024-03-31.

Net Profit (PAT) was ₹5.2Cr in 2025-03-31 compared with ₹46.7Cr in 2024-03-31.

Earnings per share (EPS) were ₹7.30 in 2025-03-31, compared with ₹65.50 in 2024-03-31.